1. Home
  2. VTRS vs LII Comparison

VTRS vs LII Comparison

Compare VTRS & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$17.31

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

Logo Lennox International Inc.

LII

Lennox International Inc.

HOLD

Current Price

$542.25

Market Cap

17.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTRS
LII
Founded
1961
1895
Country
United States
United States
Employees
30000
N/A
Industry
Medicinal Chemicals and Botanical Products
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
17.2B
IPO Year
2019
1999

Fundamental Metrics

Financial Performance
Metric
VTRS
LII
Price
$17.31
$542.25
Analyst Decision
Buy
Hold
Analyst Count
4
13
Target Price
$13.50
$566.58
AVG Volume (30 Days)
9.1M
380.7K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
3.21%
1.00%
EPS Growth
N/A
1.11
EPS
0.15
3.35
Revenue
$14,299,900,000.00
$5,195,300,000.00
Revenue This Year
$4.41
$6.85
Revenue Next Year
$1.96
$5.76
P/E Ratio
$115.50
$166.44
Revenue Growth
N/A
N/A
52 Week Low
$8.63
$434.06
52 Week High
$17.53
$689.44

Technical Indicators

Market Signals
Indicator
VTRS
LII
Relative Strength Index (RSI) 64.85 49.35
Support Level $15.82 $530.83
Resistance Level N/A $567.40
Average True Range (ATR) 0.45 16.97
MACD 0.09 -2.77
Stochastic Oscillator 82.13 22.88

Price Performance

Historical Comparison
VTRS
LII

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About LII Lennox International Inc.

Lennox International manufacturers and distributes heating, ventilating, air conditioning, and refrigeration products for the North American replacement (75% of sales) and new construction (25% of sales) markets. Residential HVAC (home comfort solutions) accounts for 67% of sales and commercial HVAC (building climate solutions) accounts for the remaining 33% of sales. Lennox's commercial exposure is what its peers refer to as residential and light commercial, and lacks the scale and complexity of what is referred to as an applied solution. The company goes to market with multiple brands, but Lennox is its flagship HVAC brand.

Share on Social Networks: